Expert consensus guidelines for community pharmacists in the management of diabetic peripheral neuropathy with a combination of neurotropic B vitamins
Issued Date
2024-01-01
Resource Type
eISSN
20523211
Scopus ID
2-s2.0-85184394289
Journal Title
Journal of Pharmaceutical Policy and Practice
Volume
17
Issue
1
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of Pharmaceutical Policy and Practice Vol.17 No.1 (2024)
Suggested Citation
Sathienluckana T., Palapinyo S., Yotsombut K., Wanothayaroj E., Sithinamsuwan P., Suksomboon N. Expert consensus guidelines for community pharmacists in the management of diabetic peripheral neuropathy with a combination of neurotropic B vitamins. Journal of Pharmaceutical Policy and Practice Vol.17 No.1 (2024). doi:10.1080/20523211.2024.2306866 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/97220
Title
Expert consensus guidelines for community pharmacists in the management of diabetic peripheral neuropathy with a combination of neurotropic B vitamins
Corresponding Author(s)
Other Contributor(s)
Abstract
This consensus guidance is for community pharmacists in diabetic peripheral neuropathy (DPN) management with a combination of neurotropic B vitamins. A multidisciplinary team including endocrinology, neurology, and pharmacy from Thailand discussed and aligned the practical scheme of DPN management in the community pharmacy setting, using the literature review and having face-to-face meeting. Five major statements have been endorsed as consensus recommendations for DPN care with strong acknowledgment. The aims of DPN management included reducing symptoms and the risk of complications, minimising adverse reactions from treatment regimens, and improving patients’ knowledge and adherence to the treatment strategies. An initial screening process using a 7 items interview of Douleur Neuropathique 4 (DN4) questionnaire should be implemented to identify patients at risk of developing DPN. Subsequently, pharmacologic, and non-pharmacologic treatment should be employed based on patient-centered care. An interesting approach is combination of neurotropic B vitamins, which may be used as monotherapy or combination therapy to control DPN symptoms. The combined therapy potentially exhibits a synergistic effect and improves patient adherence. The consensus would be further considered in context of harmonisation of routine practice and country requirements.